Advertisement
Home »

The Effectiveness and Safety of Anti-PD-L1 mAb Socazolimab in Treating Recurrent or Metastatic Cervical Cancer

Jan 13, 2023

ABOUT THE CONTRIBUTORS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement